LEXEO Lead CNS Programs

Program

Research

Pre-Clinical

Phase I / II

Phase III

LXC - 004

CLN2 Batten Disease (AAV)

LXC - 001

APOE4 Alzheimer's Disease (AAV)

 
 

Other LEXEO Programs

Currently in pre-clinical research

Optioned Programs

Program

Research

Pre-Clinical

Phase I / II

Phase III

Metachromatic Leukodystrophy (AAV)

 

Alzheimer’s Tau (AAV)

 

Chronic Traumatic Encephalopathy (AAV)

Hereditary Diseases

  • Friedreich's Ataxia

  • Alpha 1 -Antitrypsin deficiency

  • Aldehyde dehydrogenase 2 deficiency
     

Inflammation & Allergy “Vectorized” Antibodies


Oncology “Vectorized” Antibodies

lexeo reverse.png

©2020 by Lexeo Therapeutics

430 East 29th Street, 14th Floor
New York, New York

info@lexeotx.com

(212) 547-9879